Serum concentration of fentanyl during conversion from intravenous to transdermal administration to patients with chronic cancer pain.

Background:To the best of our knowledge, there have been no reports on the pharmacokinetics and pharmacodynamics during the conversion from continuous intravenous infusion (CII) to transdermal fentanyl administration. The primary objective of the present study was to clarify the pharmacokinetic char